Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients

NCT02035787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Complex Atypical Hyperplasia
Endometrial Cancer

Interventions

DRUG: Metformin

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]